Stockreport

IMNN: Positive Results for OVATION 2 Trial Supports Advancing IMNN-001 Into Phase 3 Study… [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF Positive Results from OVATION 2 Trial Support Advancing IMNN-001 to Phase 3 Study On July 30, 2024, Imunon, Inc. (NASDAQ:IMNN) announced positive topline results from [Read more]